Información del producto
ABT-072 is a pharmacokinetic inhibitor that acts as an NS5B polymerase inhibitor. It is in Phase II clinical trials for the treatment of chronic hepatitis C virus (HCV) infection. ABT-072 has demonstrated potent antiviral activity in vitro and in vivo, without any detectable cytotoxicity against human hepatocytes. In Phase I studies, ABT-072 was well tolerated and had a high bioavailability with a half-life of 15 hours. This drug also inhibits the cytochrome P450 enzyme system, which may lead to the development of drug resistance in patients with chronic HCV infections.
Propiedades químicas
Consulta técnica sobre: 3D-HVB93600 ABT-072
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
